Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP676249.RAcLrdxGuXwLbDE9iGqakPvb7oyi-51Gw4Jb3HrD223x0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP676249.RAcLrdxGuXwLbDE9iGqakPvb7oyi-51Gw4Jb3HrD223x0130_assertion type Assertion NP676249.RAcLrdxGuXwLbDE9iGqakPvb7oyi-51Gw4Jb3HrD223x0130_head.
- NP676249.RAcLrdxGuXwLbDE9iGqakPvb7oyi-51Gw4Jb3HrD223x0130_assertion description "[Loss of RRAD expression was found in 14 of 20 (70%) NSCLC cell lines, 11 of 11 (100%) SCLC cell lines, and 8 of 10 (80%) breast cancer cell lines; expression was not affected in normal bronchial and mammary epithelial cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP676249.RAcLrdxGuXwLbDE9iGqakPvb7oyi-51Gw4Jb3HrD223x0130_provenance.
- NP676249.RAcLrdxGuXwLbDE9iGqakPvb7oyi-51Gw4Jb3HrD223x0130_assertion evidence source_evidence_literature NP676249.RAcLrdxGuXwLbDE9iGqakPvb7oyi-51Gw4Jb3HrD223x0130_provenance.
- NP676249.RAcLrdxGuXwLbDE9iGqakPvb7oyi-51Gw4Jb3HrD223x0130_assertion SIO_000772 17195088 NP676249.RAcLrdxGuXwLbDE9iGqakPvb7oyi-51Gw4Jb3HrD223x0130_provenance.
- NP676249.RAcLrdxGuXwLbDE9iGqakPvb7oyi-51Gw4Jb3HrD223x0130_assertion wasDerivedFrom befree-20150227 NP676249.RAcLrdxGuXwLbDE9iGqakPvb7oyi-51Gw4Jb3HrD223x0130_provenance.
- NP676249.RAcLrdxGuXwLbDE9iGqakPvb7oyi-51Gw4Jb3HrD223x0130_assertion wasGeneratedBy ECO_0000203 NP676249.RAcLrdxGuXwLbDE9iGqakPvb7oyi-51Gw4Jb3HrD223x0130_provenance.